» Articles » PMID: 38410279

Pt-Se Hybrid Nanozymes with Potent Catalytic Activities to Scavenge ROS/RONS and Regulate Macrophage Polarization for Osteoarthritis Therapy

Overview
Specialty Biology
Date 2024 Feb 27
PMID 38410279
Authors
Affiliations
Soon will be listed here.
Abstract

The activation of pro-inflammatory M1-type macrophages by overexpression of reactive oxygen species (ROS) and reactive nitrogen species (RONS) in synovial membranes contributes to osteoarthritis (OA) progression and cartilage matrix degradation. Here, combing Pt and Se with potent catalytic activities, we developed a hybrid Pt-Se nanozymes as ROS and RONS scavengers to exert synergistic effects for OA therapy. As a result, Pt-Se nanozymes exhibited efficient scavenging effect on ROS and RONS levels, leading to repolarization of M1-type macrophages. Furthermore, the polarization of synovial macrophages to the M2 phenotype inhibited the expression of pro-inflammatory factors and salvaged mitochondrial function in arthritic chondrocytes. In vivo results also suggest that Pt-Se nanozymes effectively suppress the early progression of OA with an Osteoarthritis Research International Association score reduction of 68.21% and 82.66% for 4 and 8 weeks, respectively. In conclusion, this study provides a promising strategy to regulate inflammatory responses by macrophage repolarization processes for OA therapeutic.

Citing Articles

Regulation of immune microenvironments by polyetheretherketone surface topography for improving osseointegration.

Zhao Y, An Y, Wu F, Liu L, Tay F, Jiao Y J Nanobiotechnology. 2025; 23(1):199.

PMID: 40069791 PMC: 11895393. DOI: 10.1186/s12951-025-03272-7.


Mitochondria-Targeted Biomaterials-Regulating Macrophage Polarization Opens New Perspectives for Disease Treatment.

Tian Z, Wang X, Chen S, Guo Z, Di J, Xiang C Int J Nanomedicine. 2025; 20:1509-1528.

PMID: 39925677 PMC: 11806677. DOI: 10.2147/IJN.S505591.


Skatole Alleviates Osteoarthritis by Reprogramming Macrophage Polarization and Protecting Chondrocytes.

Wang W, Chu Y, Lu Y, Xu J, Zhao W, Liang Z Research (Wash D C). 2025; 8:0604.

PMID: 39902346 PMC: 11788598. DOI: 10.34133/research.0604.


Programmed Transformation of Osteogenesis Microenvironment by a Multifunctional Hydrogel to Enhance Repair of Infectious Bone Defects.

Xie E, Yuan Z, Chen Q, Hu J, Li J, Li K Adv Sci (Weinh). 2025; 12(10):e2409683.

PMID: 39840502 PMC: 11904992. DOI: 10.1002/advs.202409683.


Biomimetic bioreactor for potentiated uricase replacement therapy in hyperuricemia and gout.

Yang B, Luo G, Nie T, Ban Z, Ning Q, Zhang J Front Bioeng Biotechnol. 2025; 12():1520663.

PMID: 39840134 PMC: 11746906. DOI: 10.3389/fbioe.2024.1520663.


References
1.
Chung M, Chia W, Wan W, Lin Y, Sung H . Controlled Release of an Anti-inflammatory Drug Using an Ultrasensitive ROS-Responsive Gas-Generating Carrier for Localized Inflammation Inhibition. J Am Chem Soc. 2015; 137(39):12462-5. DOI: 10.1021/jacs.5b08057. View

2.
Chin K, Ima-Nirwana S . The Role of Vitamin E in Preventing and Treating Osteoarthritis - A Review of the Current Evidence. Front Pharmacol. 2018; 9:946. PMC: 6113565. DOI: 10.3389/fphar.2018.00946. View

3.
Al-Dossari M, Fadda L, Attia H, Hasan I, Mahmoud A . Curcumin and Selenium Prevent Lipopolysaccharide/Diclofenac-Induced Liver Injury by Suppressing Inflammation and Oxidative Stress. Biol Trace Elem Res. 2019; 196(1):173-183. DOI: 10.1007/s12011-019-01910-4. View

4.
Zhou F, Mei J, Yang S, Han X, Li H, Yu Z . Modified ZIF-8 Nanoparticles Attenuate Osteoarthritis by Reprogramming the Metabolic Pathway of Synovial Macrophages. ACS Appl Mater Interfaces. 2019; 12(2):2009-2022. DOI: 10.1021/acsami.9b16327. View

5.
Liang H, Peng B, Dong C, Liu L, Mao J, Wei S . Cationic nanoparticle as an inhibitor of cell-free DNA-induced inflammation. Nat Commun. 2018; 9(1):4291. PMC: 6191420. DOI: 10.1038/s41467-018-06603-5. View